Proliferation of solid tumors is a critical factor for evaluating the effectiveness of tumor treatment, with Ki-67 and VEGF serving as key indicators that reflect tumor proliferation and are crucial for assessing the prognosis of breast tumors [35,36,37,38]. This evidence concerns the gene VEGFA and neoplasm.